You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

19-333

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19, Breakthrough Infection Trial in Taoyuan city (BNT162b2, mRNA-1273, MVC-COV1901)

Active, not recruiting
  • COVID-19
  • Breakthrough Infection
  • BNT162b2
  • +2 more
  • Taoyuan city, Taiwan
    Chang Gung Memorial Hospital
Jul 21, 2022

Covid-19, Vaccine, Immunogenicity Trial in Taoyuan (Heterologous prime-boost schedule with AZD1222 and MVC-COV1901, Homologous

Recruiting
  • Covid-19
  • +4 more
  • Heterologous prime-boost schedule with AZD1222 and MVC-COV1901
  • Homologous prime-boost schedule with two doses of AZD1222
  • Taoyuan, Taiwan
    ChangGungMH
Oct 19, 2021

Melanoma Stage IIIB/C Trial in Spain, Switzerland, United States (Daromun, Surgery, Adjuvant therapy)

Recruiting
  • Melanoma Stage IIIB/C
  • La Jolla, California
  • +30 more
Dec 22, 2022

Older Adults' Perceptions of the Impact COVID-19 Pandemic

Completed
  • COVID-19 Pandemic
  • +4 more
  • Impact COVID-19 pandemic
  • Albergaria-a-Velha, Aveiro, Portugal
  • +57 more
Jul 31, 2022

Chronic Hepatitis C Virus (HCV) Infection Genotype 1 Trial in United States (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

Completed
Has Results
  • Chronic Hepatitis C Virus (HCV) Infection Genotype 1
  • Phoenix, Arizona
  • +47 more
Jun 27, 2022

Locally Advanced or Metastatic NSCLC Trial in Worldwide (Trastuzumab Deruxtecan, Cisplatin, Carboplatin)

Recruiting
  • Locally Advanced or Metastatic Non-Small Cell Lung Cancer
  • Trastuzumab Deruxtecan
  • +4 more
  • Anchorage, Alaska
  • +148 more
Aug 11, 2022

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)

Completed
Has Results
  • Chronic Hepatitis C Infection
  • ABT-450/r/ABT-267, ABT-333
  • +4 more
  • (no location specified)
Jul 29, 2021

Microbial Colonization, COVID-19 Respiratory Infection, Dysbiosis Trial in Cracovia (Oral Procedure)

Completed
  • Microbial Colonization
  • +4 more
  • Oral Procedure
  • Cracovia, Poland
    Univeristy Hospital Kraków
Oct 7, 2022

Non Hodgkin Lymphoma (NHL), Peripheral T-cell Lymphoma (PTCL), Cutaneous T-Cell Lymphoma (CTCL) Trial in United States (KT-333)

Recruiting
  • Non Hodgkin Lymphoma (NHL)
  • +4 more
  • Orange, California
  • +8 more
Nov 29, 2022

Metastatic Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Durvalumab, Paclitaxel)

Recruiting
  • Metastatic Breast Cancer
  • Trastuzumab deruxtecan
  • +4 more
  • West Hollywood, California
  • +101 more
Jan 16, 2023

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)

Completed
Has Results
  • Chronic Hepatitis C Infection
  • ABT-450/r/ABT-267, ABT-333
  • +4 more
  • (no location specified)
Jul 8, 2021

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ribavirin)

Completed
Has Results
  • Chronic Hepatitis C Infection
  • ABT-450/r/ABT-267, ABT-333
  • +2 more
  • (no location specified)
Jul 8, 2021

Questionnaires and Instruments Measurements

Recruiting
  • Detection
  • HRV and Pulse diagnosis
  • Taipei county, Taiwan
    Center for Traditional Medicine, Taipei Veterans General Hospita
May 16, 2023

Post COVID-19 Condition, Unspecified, SARS-CoV2 Infection, COVID-19 Trial (Nirmatrelvir/ritonavir, Placebo)

Not yet recruiting
  • Post COVID-19 Condition, Unspecified
  • +2 more
  • (no location specified)
May 9, 2023

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin)

Completed
Has Results
  • Chronic Hepatitis C Infection
  • (no location specified)
Jul 8, 2021

Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

Completed
Has Results
  • Chronic Hepatitis C Infection
  • Compensated Cirrhosis
  • ABT-450/r/ABT-267, ABT-333
  • Ribavirin (RBV)
  • (no location specified)
Jul 8, 2021

COVID-19 Seroprevalence in Pregnant Women and Blood Donors

Not yet recruiting
  • COVID-19 Respiratory Infection
    • (no location specified)
    Jul 12, 2022

    Hepatocellular Carcinoma Trial in Worldwide (Nivolumab, Sorafenib, Ipilimumab)

    Active, not recruiting
    • Hepatocellular Carcinoma
    • Nivolumab
    • +3 more
    • Los Angeles, California
    • +58 more
    Dec 1, 2021

    Prostate Cancer Trial in New York (drug, diagnostic test, other, procedure)

    Recruiting
    • Prostate Cancer
    • (64Cu)-labeled PSMA-targeting particle tracer, or 64Cu-NOTA-PSMAi-PEG-Cy5.5-C' dots
    • +3 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Mar 7, 2022

    Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-450/r/ABT-267, ABT-333,

    Completed
    Has Results
    • Hepatitis C Virus Infection
    • +3 more
    • (no location specified)
    Jul 8, 2021

    COVID-19 Trial in France, Germany, United Kingdom (COVID-19 convalescent and vaccinated plasma, Current standard of care)

    Recruiting
    • COVID-19
    • COVID-19 convalescent and vaccinated plasma
    • Current standard of care
    • Besançon, France
    • +10 more
    May 3, 2022

    COVID-19 Trial in Sugar Land (HB-adMSCs, Placebos)

    Completed
    Has Results
    • COVID-19
    • HB-adMSCs
    • Placebos
    • Sugar Land, Texas
      Hope Biosciences Stem Cell Research Foundation
    Oct 26, 2022

    HIV Trial (Cognitive Behavioral Therapy for Syndemics and Adherence (CBT-SA))

    Not yet recruiting
    • HIV Infections
    • Cognitive Behavioral Therapy for Syndemics and Adherence (CBT-SA)
    • (no location specified)
    Nov 21, 2023

    Covid19 Trial in Japan (Novaferon, Placebo)

    Recruiting
    • Covid19
    • Novaferon
    • Placebo
    • Chiba, Japan
    • +21 more
    Jan 13, 2022

    Healthy Volunteers Trial in Miami (ITI-333, Placebo)

    Recruiting
    • Healthy Volunteers
    • Miami, Florida
      Clinical Site
    Feb 7, 2023